Prell R - Search Results

1

Engagement of the OX-40 receptor in vivo enhances antitumor immunity.

Weinberg AD, Rivera MM, Prell R, Morris A, Ramstad T, Vetto JT, Urba WJ, Alvord G, Bunce C, Shields J. Weinberg AD, et al. Among authors: prell r. J Immunol. 2000 Feb 15;164(4):2160-9. doi: 10.4049/jimmunol.164.4.2160. J Immunol. 2000. PMID: 10657670

2

OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent.

Prell RA, Evans DE, Thalhofer C, Shi T, Funatake C, Weinberg AD. Prell RA, et al. J Immunol. 2003 Dec 1;171(11):5997-6005. doi: 10.4049/jimmunol.171.11.5997. J Immunol. 2003. PMID: 14634111

3

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

Evans DE, Prell RA, Thalhofer CJ, Hurwitz AA, Weinberg AD. Evans DE, et al. Among authors: prell ra. J Immunol. 2001 Dec 15;167(12):6804-11. doi: 10.4049/jimmunol.167.12.6804. J Immunol. 2001. PMID: 11739496

4

The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.

Weinberg AD, Evans DE, Thalhofer C, Shi T, Prell RA. Weinberg AD, et al. J Leukoc Biol. 2004 Jun;75(6):962-72. doi: 10.1189/jlb.1103586. Epub 2004 Mar 2. J Leukoc Biol. 2004. PMID: 14996827 Review.

5

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.

Maxwell JR, Weinberg A, Prell RA, Vella AT. Maxwell JR, et al. Among authors: prell ra. J Immunol. 2000 Jan 1;164(1):107-12. doi: 10.4049/jimmunol.164.1.107. J Immunol. 2000. PMID: 10605000

6

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.

Chu Y, Wang LX, Yang G, Ross HJ, Urba WJ, Prell R, Jooss K, Xiong S, Hu HM. Chu Y, et al. Among authors: prell r. J Immunother. 2006 Jul-Aug;29(4):367-80. doi: 10.1097/01.cji.0000199198.43587.ba. J Immunother. 2006. PMID: 16799332

7

Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.

Bahjat KS, Prell RA, Allen HE, Liu W, Lemmens EE, Leong ML, Portnoy DA, Dubensky TW Jr, Brockstedt DG, Giedlin MA. Bahjat KS, et al. J Immunol. 2007 Dec 1;179(11):7376-84. doi: 10.4049/jimmunol.179.11.7376. J Immunol. 2007. PMID: 18025181

8

Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.

Prell RA, Kerkvliet NI. Prell RA, et al. J Immunol. 1997 Mar 15;158(6):2695-703. J Immunol. 1997. PMID: 9058803

9

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.

Prell RA, Gearin L, Simmons A, Vanroey M, Jooss K. Prell RA, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1285-93. doi: 10.1007/s00262-005-0116-4. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408214 Free PMC article.

10

Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.

Prell RA, Li B, Lin JM, VanRoey M, Jooss K. Prell RA, et al. Cancer Res. 2005 Mar 15;65(6):2449-56. doi: 10.1158/0008-5472.CAN-04-1975. Cancer Res. 2005. PMID: 15781661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters